Exacerbation of palmoplantar pustulosis by granulocyte colony-stimulating factor.
Kurokawa
Ichiro
I
Umehara
Makiko
M
Iwai
Toshiko
T
Hamanishi
Shozo
S
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003984:Dibenzazepines / Q000627:therapeutic use; D005260:Female; D000069585:Filgrastim; D005938:Glucocorticoids / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D000078224:Lenograstim; D007970:Leukopenia / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy; D011994:Recombinant Proteins / Q000009:adverse effects; D014594:Uterine Neoplasms / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D003984:Dibenzazepines; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim; D011239:Prednisolone; D000069585:Filgrastim; C053090:epinastine